These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22297506)

  • 1. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 2. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC; Hussain SM; Terkivatan T; Zondervan PE; de Man RA
    J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 5. MR imaging of the liver. Cirrhosis and premalignant nodules.
    Ohtomo K
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):331-46. PubMed ID: 9113678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation.
    Krinsky GA; Lee VS; Theise ND
    J Comput Assist Tomogr; 2000; 24(2):189-96. PubMed ID: 10752877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
    Henninger B; Bale R; Schocke M
    Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
    [No Abstract]   [Full Text] [Related]  

  • 10. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 11. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of HCC.
    Ayuso C; Rimola J; García-Criado A
    Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
    Roncalli M; David E; Gentile A; Pollice L
    Pathologica; 2000 Jun; 92(3):210-20. PubMed ID: 10902435
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications of clinical uses of contrast agents for MR imaging of liver].
    Chen F; Ni YC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):299-300. PubMed ID: 15854502
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
    Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.